Study Discovers Why MS Drug Tysabri Increases Risk Of PML

Researchers at the US National Institute of Neurological Disorders and Stroke believe that patients taking the MS drug Tysabri face a higher risk of developing the brain disease multifocal leukoencephalopathy .

http://ift.tt/1mzMRrp